Riskpilot← Back to searchSign inGet full accessDENLUX A/S
A/SActiveCVR 28305494Metalbuen 38Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20044 employees
Revenue 2024
DKK 3,6M
-7% vs 2023
EBITDA margin
30.4%
-18% vs 2023
Equity ratio
95.1%
Financial strength
Net profit 2024
DKK 611K
-26% vs 2023
| Revenue | DKK 3,6M | -7% |
| EBITDA | DKK 1,1M | -18% |
| Net profit | DKK 611K | -26% |
| Total assets | DKK 7,3M | +1% |
| Equity | DKK 7M | +2% |
| Employees | 4 | — |
Legal name
DENLUX A/S
CVR number
28305494
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
22. december 2004
Share capital
DKK 500.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er handel, håndværk, industri og dermed beslægtet virksomhed.
Address
Metalbuen 38
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.394 | 5.116 | 5.644 | 5.151 | 5.091 | 4.779 | 4.375 | 3.780 | 4.178 | 4.316 | 4.100 | 3.823 | 3.556 |
| Staff expenses | -4.432 | -3.782 | -2.366 | -2.291 | -2.268 | -2.452 | -2.456 | -2.454 | -2.448 | -2.439 | -2.761 | -2.503 | -2.475 |
| EBITDA | 1.962 | 1.335 | 3.278 | 2.861 | 2.824 | 2.327 | 1.919 | 1.326 | 1.730 | 1.876 | 1.339 | 1.319 | 1.082 |
| Depreciation & amort. | -1.017 | -973 | -1.033 | -37 | -40 | -23 | -13 | -13 | -3 | -35 | -0 | -0 | -0 |
| EBIT | 945 | 362 | 2.244 | 2.823 | 2.784 | 2.304 | 1.905 | 1.313 | 1.727 | 1.841 | 1.339 | 1.319 | 1.082 |
| Net financials | 25 | 28 | 51 | 0 | 7 | 21 | 15 | 86 | -49 | 1 | 300 | -158 | -247 |
| Profit before tax | 969 | 390 | 2.303 | 2.824 | 2.791 | 2.325 | 1.921 | 1.399 | 1.678 | 1.842 | 1.639 | 1.161 | 835 |
| Tax | 242 | 98 | 561 | 661 | 616 | 511 | 424 | 305 | 372 | 404 | 434 | 340 | 224 |
| Net profit | 728 | 292 | 1.742 | 2.162 | 2.175 | 1.814 | 1.496 | 1.093 | 1.307 | 1.437 | 1.204 | 822 | 611 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9.242 | 8.457 | 9.473 | 10.423 | 11.142 | 11.122 | 11.028 | 10.040 | 11.818 | 11.819 | 6.956 | 7.248 | 7.346 |
| Equity | 7.528 | 7.119 | 8.861 | 10.024 | 10.698 | 10.513 | 10.509 | 9.603 | 10.910 | 11.347 | 6.551 | 6.873 | 6.984 |
| Long-term debt | 0 | 0 | 175 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.223 | 1.081 | 429 | 393 | 441 | 610 | 519 | 437 | 906 | 472 | 405 | 374 | 362 |
| Total debt | 1.223 | 1.081 | 603 | 393 | 441 | 610 | 519 | 437 | 906 | 472 | 405 | 374 | 362 |
EBITDA margin
30.4%
This company
15.8%
Market median
+92% vs market
20122024
Equity ratio
95.1%
This company
38.2%
Market median
+149% vs market
20122024
Return on equity
8.7%
This company
18.4%
Market median
-53% vs market
20122024
Net profit margin
17.2%
This company
8.1%
Market median
+112% vs market
20122024
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20122024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JL Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2004 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PHILIP J. HANSEN HOLDING ApS | Company | 50.0% | 50.0% | 2022 |
J. LUND INVEST ApS | Company | 50.0% | 50.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
J. LUND INVEST ApS
DENLUX A/S Board members of DENLUX A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Lund | Chief Executive Officer | 0 companies |
| Flemming Julin Hansen | Board of Directors | 0 companies |
| Philip Julin Hansen | Board of Directors | 0 companies |